Meno Martha and HT 2017 Update for Chronic ConditionsAre you postmenopausal and would like a magic pill for the prevention of heart disease, stroke, diabetes, dementia, cancer and bone fractures? So would I.

Unfortunately hormone therapy (HT) is not that magic pill.

Although HT “is one of the most effective treatments available for bothersome hot flashes and night sweats”, HT in postmenopausal women is not recommended for the primary prevention of chronic conditions such as heart disease, stroke, diabetes, dementia, cancer and bone fractures.

In December 2017, the (United States) Preventative Services Task Force (USPSTF) updated their 2012 recommendations about the use of HT in postmenopausal women for the primary prevention of chronic conditions.

In Hormone Therapy In Postmenopausal Women: Primary Prevention of Chronic Conditions the USPSTF’s Final Recommendation Statement, dated 12 December 2017, includes:Meno Martha and HT 2017 Update for Chronic Conditions

“Postmenopausal women
The USPSTF recommends against the use of combined estrogen and progestin for the primary prevention of chronic conditions in postmenopausal women”.

In Hormone Therapy In Postmenopausal Women: Primary Prevention of Chronic Conditions the USPSTF’s Final Recommendation Statement, dated 12 December 2017, also includes:Meno Martha and HT 2017 Update for Chronic Conditions

“Postmenopausal women who have had a hysterectomy
The USPSTF recommends against the use of estrogen alone for the primary prevention of chronic conditions in postmenopausal women who have had a hysterectomy”.

In Health Topics A-Z you may find:

Your Country may have Links similar to:

Meno Martha
Last Updated: 17 January 2019 – Last Revised: 18 December 2017
image_pdf